Westwood-Squibb Pharmaceuticals
Executive Summary
Exec VP Jeffrey Marsh named president of the Bristol-Myers Squibb subsidiary. He will replace Wilfred Larson, who is retiring effective April 1. SquibbDerm combined with Westwood to form the new division in October.